Be Cool: An Innovative and Holistic Psychoeducational Program for Multiple Sclerosis Individuals
BeCool
1 other identifier
observational
30
1 country
1
Brief Summary
This observational study aims to investigate the impact of an online psychoeducational program, combined with cooling therapy, nutrition, psychological intervention, and exercise, on the resilience, treatment adherence, symptom management, and quality of life of individuals with Multiple Sclerosis. The study will last for six months, during which two groups of 15 participants with similar characteristics and a diagnosis of Multiple Sclerosis will take part in the protocol. Group A will follow the research protocol, while Group B, the Control group, will not participate in any rehabilitation intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedFirst Submitted
Initial submission to the registry
December 18, 2023
CompletedFirst Posted
Study publicly available on registry
February 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2024
CompletedMay 8, 2024
May 1, 2024
1 month
December 18, 2023
May 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
anxiety and depression
This will be estimated with the "The Hospital Anxiety and Depression Scale - HADS". The Hospital Anxiety and Depression Scale (HADS) is a widely used questionnaire specifically designed to identify and measure the levels of anxiety and depression in individuals. It is particularly useful in medical settings, as it helps distinguish between psychological distress and physical illness.
Baseline, after three months and at the end of the six months
Overall quality of life, namely satisfaction with their life
This will be estimated with the questionnaire of Multiple Sclerosis Quality of Life-54 (MSQOL-54)
Baseline, after three months and at the end of the six months
Perception of stress
Perceived Stress Scale (PSS) will be used. This is a widely used psychological instrument for measuring the perception of stress. It assesses the degree to which situations in one's life are appraised as stressful. Items on the PSS ask about feelings and thoughts during the last month, and scores on the PSS can range from 0 to 40, with higher scores indicating higher perceived stress.
Baseline, after three months and at the end of the six months
Cognitive fusion which refers to the degree to which an individual's thoughts and feelings are intertwined with their sense of self, often leading to an inability to separate from, or 'defuse' from, these internal experiences.
The Cognitive Fusion Questionnaire (CFQ-7) questionnaire that measures cognitive fusion, which a key concept in Acceptance and Commitment Therapy (ACT) will be used. The CFQ-7, with its 7 items, assesses the extent to which a person experiences this phenomenon.
Baseline, after three months and at the end of the six months
The value of living
The Valued Living Questionnaire (VLQ) will be used. The VLQ is designed to assess valued living, which is another core concept in ACT. It helps individuals to identify what is truly important and meaningful to them in various domains of life (such as family, career, health) and to what extent they have been living in accordance with these values.
Baseline, after three months and at the end of the six months
Psychological flexibility which is the ability to be in the present moment with full awareness and openness to experiences, and to take action guided by one's values.
The MPFI-Psychological Flexibility Subscale will be used. This subscale is part of a larger questionnaire and specifically measures psychological flexibility, an essential aspect of mental health and well-being.
Baseline, after three months and at the end of the six months
The resilience which is defined as the ability to cope with and bounce back from adversity.
The Connor-Davidson Resilience Scale (CDRISC-25) will be used. This 25-item scale measures resilience, defined as the ability to cope with and bounce back from adversity. Higher scores indicate greater resilience.
Baseline, after three months and at the end of the six months
Aerobic capacity and ability to walk
The Two Minute Walk Test (2MWT) is a simple, easy-to-administer functional exercise test used primarily in clinical settings. It measures the distance an individual is able to walk on a flat, hard surface in a period of two minutes.
Baseline, after three months and at the end of the six months
Lower body strength and functional mobility
The Five Times Sit to Stand Test (5xSST) will be used which is a simple yet effective physical performance test used primarily to assess lower body strength and functional mobility. The test involves timing how long it takes an individual to stand up and sit down five times as quickly as possible from a standard height chair without using their arms for support. A longer time to complete the test generally indicates lower functional performance.
Baseline, after three months and at the end of the six months
Static and dynamic balance ability
The Berg Balance Scale (BBS) will be used which is a widely used clinical test of a person's static and dynamic balance abilities. It is particularly common in elderly populations and among those recovering from injury or dealing with conditions that affect balance.
Baseline, after three months and at the end of the six months
Mobility and walking speed
The Timed 25-Foot Walk (T25-FW) will be used which is a functional test commonly used to assess mobility and walking speed in individuals, particularly those with neurological conditions such as multiple sclerosis (MS).The test involves timing how quickly a person can walk 25 feet at their usual pace, usually conducted along a flat, straight course.
Baseline, after three months and at the end of the six months
Secondary Outcomes (4)
Finger dexterity and arm-hand coordination
Baseline, after three months and at the end of the six months
Core temperature
Baseline, after three months and at the end of the six months
Skin temperature
Baseline, after three months and at the end of the six months
Nutritional status, how balance is their nutrition
Baseline, after three months and at the end of the six months
Study Arms (2)
Experimental group
The experimental group will attend a structured psychoeducational program developed to build and promote psychological flexibility. In combination with this, participants of this group will have to follow a head and neck cooling protocol. Also, participants of this group will be required to increase their habitual exercise levels and follow a video exercise program specifically designed for their needs and improve their nutrition based on the instructions of a nutritionist and videos specially designed for them.
Control group
As per the study plan, the Control group has been designated as the control group. They will continue with their normal lifestyle without any participation in rehabilitation activities or programs.
Interventions
The psychoeducational program will be conducted through weekly online video-conferencing group sessions that will last for two hours. In addition to these sessions, participants will receive psychoeducational material such as readings, videos, podcasts, worksheets, and homework exercises every week. This material will allow participants to practice at their own pace during the session intervals. The exercise training program for individuals with MS will be tailored to meet the unique and individual needs of each participant. To achieve this, a head and neck cooling protocol will be implemented using commercially available cooling equipment, specifically the Headcool Power and Neckcool Tie from Inuteq. Participants will need to wear the cooling cup and neck wrap for two hours daily. The equipment will be activated using 10°C tap water. Finally, a nutritionist will provide personalized nutritional guidance including weekly diet observation and recipe videos.
Eligibility Criteria
Participants will be recruited from the GMSS (https://gmss.gr/) based on specific inclusion and exclusion criteria.
You may qualify if:
- Participants must have been diagnosed with MS using the McDonald criteria, ensuring a standardized and validated diagnostic approach.
- Participants should have been relapse-free during the six months leading up to the study to avoid potential confounding factors.
- Participants must have no musculoskeletal impediment that could affect their ability to engage in the exercise component of the program.
- Participants must have a score on the Expanded Disability Status Scale (EDSS) ranging from 0 to 5.5, indicating ambulatory ability without the need for a cane for at least 100 meters.
- Participants should have a history of sensitivity to heat, as reported by their treating physician, justifying the need for cooling therapy as part of the hybrid program.
- Participants must not have used cooling therapy or participated in any form of exercise training for at least four months prior to their participation in the study.
You may not qualify if:
- Previously diagnosed conditions known to impact physiological responses to heat exposure, including diabetes mellitus, hypertension, heart disease, or kidney disease.
- Use of medications to manage MS-related symptoms, such as antidepressants, psychostimulants, anticonvulsants, antispasmodics, and anticholinergic drugs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Greek Multiple Sclerosis Society
Thessaloniki, Central Macedonia, 55132, Greece
Related Publications (1)
Kaltsatou A, Flouris AD. Impact of pre-cooling therapy on the physical performance and functional capacity of multiple sclerosis patients: A systematic review. Mult Scler Relat Disord. 2019 Jan;27:419-423. doi: 10.1016/j.msard.2018.11.013. Epub 2018 Nov 13.
PMID: 30544086BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Anastasios Orologas, MD, PhD
Greek Multiple Sclerosis Society
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Adjunct Lecturer
Study Record Dates
First Submitted
December 18, 2023
First Posted
February 8, 2024
Study Start
June 1, 2023
Primary Completion
July 1, 2023
Study Completion
February 28, 2024
Last Updated
May 8, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share
Once the protocol is completed and published, all the data will be available upon request to other researchers.